Hikma Pharmaceuticals Plc Stock Price Patterns
| HKMPF Stock | USD 20.69 1.61 7.22% |
Momentum 38
Sell Extended
Oversold | Overbought |
Using Hikma Pharmaceuticals hype-based prediction, you can estimate the value of Hikma Pharmaceuticals PLC from the perspective of Hikma Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Hikma Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Hikma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Hikma Pharmaceuticals after-hype prediction price | USD 20.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Hikma |
Hikma Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Hikma Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hikma Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Hikma Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Hikma Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Hikma Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hikma Pharmaceuticals' historical news coverage. Hikma Pharmaceuticals' after-hype downside and upside margins for the prediction period are 19.13 and 22.25, respectively. We have considered Hikma Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Hikma Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Hikma Pharmaceuticals PLC is based on 3 months time horizon.
Hikma Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Hikma Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hikma Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hikma Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 1.56 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
20.69 | 20.69 | 0.00 |
|
Hikma Pharmaceuticals Hype Timeline
Hikma Pharmaceuticals PLC is currently traded for 20.69. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Hikma is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.01%. %. The volatility of related hype on Hikma Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 20.69. About 30.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hikma Pharmaceuticals PLC has Price/Earnings To Growth (PEG) ratio of 2.35. The entity last dividend was issued on the 18th of August 2022. Assuming the 90 days horizon the next projected press release will be in a few days. Check out Hikma Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Hikma Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Hikma Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Hikma Pharmaceuticals' future price movements. Getting to know how Hikma Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hikma Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HLBBF | H Lundbeck AS | 0.00 | 0 per month | 0.00 | (0.19) | 0.00 | (0.86) | 12.55 | |
| HLUBF | H Lundbeck AS | 0.00 | 0 per month | 0.00 | (0.01) | 0.00 | 0.00 | 15.66 | |
| GZPHF | Guangzhou Baiyunshan Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.05) | 0.00 | 0.00 | 9.35 | |
| SGFEF | Siegfried Holding AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OPHLY | Ono Pharmaceutical Co | 0.00 | 0 per month | 1.07 | 0.23 | 2.82 | (1.91) | 7.10 | |
| LVZPF | Livzon Pharmaceutical Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OPHLF | Ono Pharmaceutical Co | 0.00 | 0 per month | 5.68 | 0.1 | 15.65 | (12.89) | 40.31 | |
| SMDPY | Sumitomo Pharma Co | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 28.82 | |
| DNPUF | Sumitomo Dainippon Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FLMNF | Fielmann Aktiengesellschaft | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 33.82 |
Hikma Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Hikma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hikma using various technical indicators. When you analyze Hikma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Hikma Pharmaceuticals Predictive Indicators
The successful prediction of Hikma Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Hikma Pharmaceuticals PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Hikma Pharmaceuticals based on analysis of Hikma Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Hikma Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hikma Pharmaceuticals's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Hikma Pink Sheet analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |